Envestnet Asset Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,104
| Closed | -$14.2K | – | 4180 |
|
|
2023
Q4 | $14.2K | Sell |
1,104
-646
| -37% | -$8.29K | ﹤0.01% | 4027 |
|
|
2023
Q3 | $64.7K | Buy |
1,750
+567
| +48% | +$21K | ﹤0.01% | 3917 |
|
|
2023
Q2 | $47.6K | Sell |
1,183
-90
| -7% | -$3.62K | ﹤0.01% | 3874 |
|
|
2023
Q1 | $92.3K | Buy |
1,273
+701
| +123% | +$50.8K | ﹤0.01% | 3805 |
|
|
2022
Q4 | $46.9K | Sell |
572
-70
| -11% | -$5.74K | ﹤0.01% | 3873 |
|
|
2022
Q3 | $61K | Buy |
642
+224
| +54% | +$21.3K | ﹤0.01% | 3795 |
|
|
2022
Q2 | $81K | Sell |
418
-64
| -13% | -$12.4K | ﹤0.01% | 3777 |
|
|
2022
Q1 | $112K | Buy |
+482
| New | +$112K | ﹤0.01% | 3787 |
|
|
2018
Q3 | – | Sell |
-79
| Closed | -$72K | – | 1334 |
|
|
2018
Q2 | $72K | Buy |
79
+11
| +16% | +$10K | ﹤0.01% | 2084 |
|
|
2018
Q1 | $66K | Buy |
68
+28
| +70% | +$27.2K | ﹤0.01% | 2051 |
|
|
2017
Q4 | $18K | Sell |
40
-18
| -31% | -$8.1K | ﹤0.01% | 2537 |
|
|
2017
Q3 | $24K | Buy |
58
+3
| +5% | +$1.24K | ﹤0.01% | 2457 |
|
|
2017
Q2 | $19K | Sell |
55
-1
| -2% | -$345 | ﹤0.01% | 2599 |
|
|
2017
Q1 | $29K | Buy |
56
+4
| +8% | +$2.07K | ﹤0.01% | 2587 |
|
|
2016
Q4 | $19K | Buy |
+52
| New | +$19K | ﹤0.01% | 2672 |
|